PATHOGENESIS OF
GLOMERULONEPHRITIS
ADETUNJI TA
OUTLINE
• INTRODUCTION
• EPIDEMIOLOGY
• RELEVANT ANATOMY
• DEFINITION OF TERMS
• CLASSIFICATION
• PATHOGENESIS
• HISTOLOGY
• MANAGEMENT
• CONCLUSION
INTRODUCTION
• GN can be defined as a spectrum of renal diseases
of varied etiology and clinical presentations that are
characterized by clinical and histological evidence of
glomerular damage.
•Note that despite the “itis” in GN, inflammation per se
may not feature in many GNs. Associated terms include:
•Glomerulonephritides
•Glomerulopathy
•Nephritis
GLOMERULONEPHRITIDES–ThepathophysiologyGLOMERULONEPHRITIDES–Thepathophysiology
INTRODUCTION
The term Glomerulonephritis and Glomerulopathy are
usually used interchangeably to denote glomerular injury,
although some authorities reserve the former term for
injury with evidence of inflammation such as leucocyte
infiltration, antibody deposition, and complement activation
•It encompasses a group of disorders with wide-
ranging clinical presentations,severity,causes and
immunopathogenetic mechanisms
•GN is an important cause of both acute and chronic
kidney Disease worldwide.
STRUCTURE OF THE KIDNEY
•The functioning unit of the kidney is the nephron
•Each kidney has about one million nephrons
•The number of nephrons is established during prenatal
development.
•After birth, no new nephron can develop and a lost
nephron cannot be replaced.
Gross Anatomy • KIDNEYS
– Paired organ
– Each weigh 120 – 200g
– Dimensions: 10 – 12 cm
vertically, 5 -7 cm
transversely, and 3 cm
anteroposteriorly.
– The outer surface can be
divided into anterior side,
dorsal side, upper pole and
lower pole
– The lateral surface is
convex.
– The medial surface is
concave, deeply grooved
(renal sinus) and forms the
renal hilum
– The ureter/renal pelvis,
renal artery, renal vein,
lymphatic vessels and
nerves enter or exit
through the renal hilum the
kidney.
GENERAL ARCHITECTURE OF THE
KIDNEY
•Kidney
–Outer cortex
–Inner medulla
•Vasculature
–the arterial system
–Venous system
–the resistance vessels
•THE GLOMERULUS
•Structural characteristics of the
glomerular capillary wall
–the endothelial cell
–the glomerular visceral epithelial cell
–the mesangial cell
–the extracellular matrix: basement
membrane, (GBM’s and mesangial matrix)
•Filtration depends on
–Hydrostatic pressure difference
–Size of the molecule
–Charge on the molecule
ANATOMY
EPIDEMIOLOGY
•GN is recognized as the second commonest cause of
CKD worldwide.
•In developed countries, it is still the 3rd
commonest
cause of ESRD in many countries.
•In developing countries, it ranks 2nd
or 1st
•For every patient with clinically apparent GN receiving
medical care, an estimated additional 5 to 10 patients have
undiagnosed sub-clinical disease.
EPIDEMIOLOGY ... NIGERIA
•GN is more common in the male than in the female
population 1.4 : 1
•Peak incidence for AGN is usually October – January
( Etuk et al)
•Case average of 7.5/year calabar - to 14.5/year in
UPTH.
•GN is the commonest cause of CKD in Nigeria from
available reports
GLOSSARY OF DESCRIPTIVE TERMS
•All glomeruli
–Diffuse: Involving ≥ 50% of the glomeruli
–Focal: Involving <50% of glomeruli
•Individual glomerulus
–Global: if all or almost all of the glomerular tuft are
involved
–Segmental: if only part of the glomerulus is
involved.
GLOSSARY OF DESCRIPTIVE TERMS
•Sclerosis refers to an increase in the amount of
homogenous non-fibrillar extracellular material of similar
composition to GBM and mesangial matrix.
•Fibrosis refers to deposition of collagen type I and III
and is more commonly a consequence of healing of
crescents or tubulointerstitial inflammation.
GLOSSARY OF DESCRIPTIVE TERMS
•Proliferative is used to describe an increase in glomerular
cell number, which can be either
–true proliferation of resident glomerular cells or
–glomerular hypercellularity caused by infiltration of
leucocytes.
•Proliferation of resident glomerular cells is classified as
– intracapillary or endocapillary when referring to
endothelial or mesangial cells and
–extracapillary when referring to cells in Bowman’s
GLOSSARY OF DESCRIPTIVE TERMS
•A crescent is a half-moon-shaped collection of cells in
Bowman’s space, usually composed of proliferating
parietal epithelial cells and infiltrating macrophages.
•Because crescentic GN is often associated with renal
failure that progresses rapidly over weeks to months, the
clinical term rapidly progressive GN and the pathologic
term crescentic GN are often used interchangeably.
GLOSSARY OF DESCRIPTIVE TERMS
•Sub-epithelial – Located between the glomerular
basement membrane and the podocytes.
•Intra-membranous – within the basement membrane
•Sub-endothelial - Between the glomerular basement
membrane and the endothelium
•Mesangial – within the mesangium
CLASSIFICATION ACCORDING TO
AETIOLOGY
•Primary: idiopathic but usually immune mediated
•Secondary: there is a known cause
CLASSIFICATION ACCORDING TO
CELLULAR RESPONSE/APPEARANCE OF
THE GLOMERULAR TUFT
•Non-proliferative
•Proliferative
CLASSIFICATION
ACCORDING TO HISTOLOGIC
PATTERN
•Focal segmental
•Diffuse
•MCD
•Membranous
•Menbranousproliferative
CLASSIFICATION OF ACCORDING
TO DURATION OF DISEASE
•Acute GN refers to glomerular injury occurring over
days to weeks.
•Sub-acute or rapidly progressive GN refers to
glomerular injury occurring over weeks or a few months.
•Chronic GN refers to glomerular injury occurring over
months or years.
CLASSIFICATION BASED ON
IMMUNOFLUORESCENCE
•Immune
•Pauci immune
GN….BASIC DIVISION
•Non- Proliferative
•Minimal change
•Membranous
•FSGS
•Diabetes
•Amyloidosis
•Proliferative
•Diffuse proliferative
•(crescents)
•Mesangiocapillary
•Focal and segmental
proliferative.
All these are Histological patterns and NOT a diagnosis
PATHOGENESIS OF GLOMERULAR
INJURY
•Pathogenesis of glomerular injury involves a complex
interplay between
•Genetic factors eg congenital Nephrotic syndrome
•Acquired: Immune and Non—immune Factors
Immune Mechanisms
–Cellular immunity
–Humoral immunity
–Complement system/cascade
–Coagulation cascade
–Soluble factors
Mechanisms of Glomerulonephritis
Cell-mediated immune mechanismsAntibody deposits
Compliment activation Influx of circulating leucocytes and
cytokine and growth factor synthesis
Glomerulonephritis
Activation of resident cells
Change in matrix
On-off
switch
Scarring Resolution
Persistant inflamation Exit of inflammatory molecules and leukocytes
Genetic factors Hemodynamic factors
PATHOPHYSIOLOGY.
PATHOPHYSIOLOGY….schematics
Genetic Factors
• Congenital Nephrotic Syndrome
- Mutations in nephrin
- Mutation in podocin
- Mutation in alpha Actinin 4
• Alport Syndrome
• Thin basement membrane Disease
Immune Factors
•Central to the pathogenesis GN is inflammation which
is often immune mediated.
•Glomeruli have three properties that make them
vulnerable to immunological attack:
–they “filter” and trap immune complexes
–they contain immunologically competent cells capable
of processing antigen
–they have structures like the GBM and mesangial cells
which can act as “targets” for antibodies
Circulating Immune Complex
• In conditions such as
- SLE
- HBV Infection
- Malaria P. Falciparum and Malariae
- Syphillis
- Strptococcal infection
• Deposition of immune complexes in the glomerulus
which leads to complement activation, leucocytes
recruitment, coagulation cascade activation and
inflammation ensues
In-Situ Immune Complexes
• Seen in Anti-GBM Ab GN
• Ab directed to fixed antigens on the GBM
• Ab may also react in situ with previously planted non-
glomerular antigens such as DNA, IgG, bacterial
products
• Ab deposition shows a linear pattern while planted
antigens induce a granular pattern of immunoglobulin
deposition on immunoflorescence
• Ant-GBM can also cross react with alveolar basement
membrane leading to simultaneous kidney/lung lesions
as obtained in GoodPasture Syndrome.
• Α3 chain of type IV collagen is the target antigen in anti-
GBM disease (Goodpasture’s syndrome
Cell mediated Immune GN
•Cell-mediated immune mechanisms
•A direct role of T cells in mediating proteinuria and
crescent formation been suggested
•T cells sensitized to endogenous or exogenous antigen
present in the glomeruli recruit macrophages, resulting in a
local delayed type hypersensitivity reaction.
•There maybe no ab or immune complex deposition
and and when present may not correlate with disease
severity.
Mediators Of Immune Injury
•Main pathway of Ab-mediated injury is complement-
leucocyte mediated
•Acute injury: Predominant infiltrating cells are neutrophils
and monocytes
•Chronic injury:Predominant cells are
monocytes/macrophages and T cells.
•The primary mechanism for attracting these cells is the
secretion of chemokines and the expression of leucocyte
adhesion molecules by local endothelial and resident cells;
•Local release of complement activation fragments (C5a) is
very crucial(Chemotactic agent)
Soluble Factors
•Soluble factors play a role in the pathogenesis of glomerular
disease.
•Examples of soluble factors are; cytokines, chemokines,
growth factors vasoactive mediators, reactive oxygen
species, proteases, proteins in the coagulation cascade
•These factors
–promote recruitment and activation of inflammatory cells,
–activate resident glomerular cells,
–directly cause tissue injury,
–stimulate production of matrix proteins (which forms the
basis of scarring).
Non-immune Factors
• Podocyte Injury
• Nephron Loss
- Any renal condition causing significant nephron
destruction and reduced GFR
- Adaptive changes in the kidney such as hypertrophy to
remain renal fxn occurs
- Associated maladaptive haemodynamic changes
utimately perpertutes renal damage and a vicious cycle
ensues
PATHOPHYSIOLOGY… minimal change
dxs
VARIANT OF FSGS
PATHOPHYSIOLOGY…MEMBRANOUS
NEPHROPATHY
PATHOPHYSIOLOGY…
MEMBRANOPROLIFERATIVE
PATHOPHYSIOLOGY…. GOODPASTURE
DISEASE
LIGHT MICROGRAPH OF A NORMAL
GLOMERULUS.
There are only 1 or 2 cells per capillary tuft, the capillary lumens are open,
the thickness of the glomerular capillary wall (long arrow) is similar to that
of the tubular basement membranes (short arrow), and the mesangial cells
and mesangial matrix are located in the central or stalk regions of the tuft
(arrows).
HISTOLOGY ....MESANGIAL
PROLIFERATIVE
Normal glomerulus Mesangial proliferative
HISTOLOGY ....MESANGIAL
PROLIFERATIVE
•Normal •Mesangial proliferative
Light micrograph in membranoproliferative glomerulonephritis showing a lobular
appearance of the glomerular tuft with focal areas of increased glomerular
cellularity (large arrows), mesangial expansion (*), narrowing of the capillary
lumens, and diffuse thickening of the glomerular capillary walls (small arrows).
HISTOLOGY .... DIFFUSE
•Normal glomerulus
Diffuse endocapillary hypercellularity:
post-streptococcal GN
HISTOLOGY ....MEMRANOUS
NEPHROPATHY
HISTOLOGY ..... FOCAL SEGMENTAL
GLOMERULOSCLEROSIS
HISTOLOGY... FOCAL SEGMENTAL
GLOMERULOSCLEROSIS
HISTOLOGY... SCLEROSED
GLOMERULAR TUFTS
PATHOGENESIS – CHRONIC
PROGRESSIVE PHASE
•Renal damage in the chronic-progressive phase of GN
is mediated by non-immune mechanisms that develop as a
result of loss of filtering-surface with accompanying
increases in glomerular pressures in remaining nephrons.
•These features lead to glomerular sclerosis as well as
to chronic interstitial fibrosis, which is a consequence of
multiple injurious events including ischaemia, glomerular
cytokine release, and toxic effects of increased protein
filtration on tubules
MGT:HISTORY
•Family history of kidney disease and hearing difficulties
(Alport syndrome)
•Medication e.g NSAID’s ACEI, penicillamine, gold,
mercury in some skin lightening creams.
•Recent throat infection PSGN or Viral Wegener’s
granulomatosis, IgA.
•Cancer - Solid tumors, Hodgkin’s (minimal change) or
non Hodgkin’s (MPGN)
PHYSICAL EXAMINATION
•Inspection – appearance, colour, pitting oedema,
xanthelasma, alopecia, facial rash, purpura, clubbing,
livedo reticularis
•Palpation – pulse, hepatomegaly, palpable kidneys,
splenomegaly, palapable bladder
•Percussion – hepatomegaly, splenomegaly
•Auscultation – renal artery bruits, other bruits, cardiac
lesions, hypertension,
CLINICAL FEATURES OF GN
CLINICAL FEATURES OF GN
• .
.
Useful Blood Tests in Investigations of Glomerular Disease
•FBC – High white cell count in vasculitis, infections.
•E &U,Cr – assesses severity of renal impairment
•Total serum protein, albumin – Low in those with nephrotic syndrome
•Immunoglobulins – High in vasculitis, SLE
•Complement
•Low C3, normal C4 in MPGN (type II) and sometimes SLE.
•high C3, C4 in systemic vasculitis
•Antiglomerular BM antibody – Goodpasture’s disease
•Anti-dsDNA antibodies – SLE
•C3 nephritic factor – MPGN (type II)
Investigations…
•Urinalysis
•Urine Microscopy for cellular elements and casts
•24 hr urinary protein estimation
•Creatinine clearance or estimated GFR
•Renal ultrasound
•HBsAg, anti-HCV, HIV
•ANCA (antineutrophil cytoplasmic antibodies)
•Renal Biopsy
–Light microscopy
–Electron microscopy
–Immunofluorescence
Treatment
•Control of blood pressure
–ACE inhibitors ± ARBs
–Other anti-hypertensives
•Blood pressure goal < 125 / 75 mm Hg if proteinuria is > 1 g /day and < 130 /
80mmHg if proteinuria is < 1 g / day.
•Corticosteroids
–Are effective in several types of GN owing to their ability to inhibit activity of the
transcription factor nuclear factor ĸB and consequently inhibit the proinflammatory effects of
cytokines known to promote glomerular inflammation actively, including interleukin 1β and
tumour necrosis factor α.
–Are useful in several types of GN
•Lipid lowering agents e.g. statins
TREATMENT
•Corticosteroids
•Inhibits activity of the transcription nuclear factors kB and
consequently inhibit the pro-inflammatory effects of cytokines, known
to promote glomerular inflammatory actively, including IL-Iβ and TNFα
•Immunosuppressive therapies – crescentic GN, proliferative GN,
FSGS, MCD, MN, IgAN with deteriorating renal function and
proteinuria.
•Plasmapheresis – removal of preformed antibodies from the
circulation – Goodpasture’s disease
TREATMENT
•Immunosuppressives e.g. cyclophosphamide,
azathioprine, chlorambucil, mycophenolate mofetil,
sirolimus
–Are of proven benefit in crescentic GN, proliferative
lupus nephritis, focal and segmental glomerulosclerosis,
minimal change disease, membranous nephropathy, and in
cases of IgA nephropathy with deteriorating renal function
and proteinuria.
Conclusion
• Glomerulonephritis refers to a spectrum of
aetiopathogenesis and varied clinical presentations
following glomerular damage
• Results from complex interplay of genetic, immunologic
and environmental factors
• Histologic difference abound depending mostly on
aetiology
• May result in Acute or Chronic kidney disease
• Leading cause of CKD worldwide, commonest Cause in
Nigeria and Sub-Sahara Africa
• Management requires early recognition by meticulous hx
taking, examination and appropriate investigation
• Some would require Steroid +/- Immunosuppressants
References
• Basic Pathology By Robins, 8th
ed
• Harrison’s Principles of Internal Medicine By Longo et al,
18th
ed
• WACP Revision Course, 2011
• www.pubmed.gov
THANK YOU

Pathogenesis of Glomerulonephritis

  • 1.
  • 2.
    OUTLINE • INTRODUCTION • EPIDEMIOLOGY •RELEVANT ANATOMY • DEFINITION OF TERMS • CLASSIFICATION • PATHOGENESIS • HISTOLOGY • MANAGEMENT • CONCLUSION
  • 3.
    INTRODUCTION • GN canbe defined as a spectrum of renal diseases of varied etiology and clinical presentations that are characterized by clinical and histological evidence of glomerular damage. •Note that despite the “itis” in GN, inflammation per se may not feature in many GNs. Associated terms include: •Glomerulonephritides •Glomerulopathy •Nephritis GLOMERULONEPHRITIDES–ThepathophysiologyGLOMERULONEPHRITIDES–Thepathophysiology
  • 4.
    INTRODUCTION The term Glomerulonephritisand Glomerulopathy are usually used interchangeably to denote glomerular injury, although some authorities reserve the former term for injury with evidence of inflammation such as leucocyte infiltration, antibody deposition, and complement activation •It encompasses a group of disorders with wide- ranging clinical presentations,severity,causes and immunopathogenetic mechanisms •GN is an important cause of both acute and chronic kidney Disease worldwide.
  • 5.
    STRUCTURE OF THEKIDNEY •The functioning unit of the kidney is the nephron •Each kidney has about one million nephrons •The number of nephrons is established during prenatal development. •After birth, no new nephron can develop and a lost nephron cannot be replaced.
  • 6.
    Gross Anatomy •KIDNEYS – Paired organ – Each weigh 120 – 200g – Dimensions: 10 – 12 cm vertically, 5 -7 cm transversely, and 3 cm anteroposteriorly. – The outer surface can be divided into anterior side, dorsal side, upper pole and lower pole – The lateral surface is convex. – The medial surface is concave, deeply grooved (renal sinus) and forms the renal hilum – The ureter/renal pelvis, renal artery, renal vein, lymphatic vessels and nerves enter or exit through the renal hilum the kidney.
  • 7.
    GENERAL ARCHITECTURE OFTHE KIDNEY •Kidney –Outer cortex –Inner medulla •Vasculature –the arterial system –Venous system –the resistance vessels •THE GLOMERULUS •Structural characteristics of the glomerular capillary wall –the endothelial cell –the glomerular visceral epithelial cell –the mesangial cell –the extracellular matrix: basement membrane, (GBM’s and mesangial matrix) •Filtration depends on –Hydrostatic pressure difference –Size of the molecule –Charge on the molecule
  • 8.
  • 9.
    EPIDEMIOLOGY •GN is recognizedas the second commonest cause of CKD worldwide. •In developed countries, it is still the 3rd commonest cause of ESRD in many countries. •In developing countries, it ranks 2nd or 1st •For every patient with clinically apparent GN receiving medical care, an estimated additional 5 to 10 patients have undiagnosed sub-clinical disease.
  • 10.
    EPIDEMIOLOGY ... NIGERIA •GNis more common in the male than in the female population 1.4 : 1 •Peak incidence for AGN is usually October – January ( Etuk et al) •Case average of 7.5/year calabar - to 14.5/year in UPTH. •GN is the commonest cause of CKD in Nigeria from available reports
  • 11.
    GLOSSARY OF DESCRIPTIVETERMS •All glomeruli –Diffuse: Involving ≥ 50% of the glomeruli –Focal: Involving <50% of glomeruli •Individual glomerulus –Global: if all or almost all of the glomerular tuft are involved –Segmental: if only part of the glomerulus is involved.
  • 12.
    GLOSSARY OF DESCRIPTIVETERMS •Sclerosis refers to an increase in the amount of homogenous non-fibrillar extracellular material of similar composition to GBM and mesangial matrix. •Fibrosis refers to deposition of collagen type I and III and is more commonly a consequence of healing of crescents or tubulointerstitial inflammation.
  • 13.
    GLOSSARY OF DESCRIPTIVETERMS •Proliferative is used to describe an increase in glomerular cell number, which can be either –true proliferation of resident glomerular cells or –glomerular hypercellularity caused by infiltration of leucocytes. •Proliferation of resident glomerular cells is classified as – intracapillary or endocapillary when referring to endothelial or mesangial cells and –extracapillary when referring to cells in Bowman’s
  • 14.
    GLOSSARY OF DESCRIPTIVETERMS •A crescent is a half-moon-shaped collection of cells in Bowman’s space, usually composed of proliferating parietal epithelial cells and infiltrating macrophages. •Because crescentic GN is often associated with renal failure that progresses rapidly over weeks to months, the clinical term rapidly progressive GN and the pathologic term crescentic GN are often used interchangeably.
  • 15.
    GLOSSARY OF DESCRIPTIVETERMS •Sub-epithelial – Located between the glomerular basement membrane and the podocytes. •Intra-membranous – within the basement membrane •Sub-endothelial - Between the glomerular basement membrane and the endothelium •Mesangial – within the mesangium
  • 16.
    CLASSIFICATION ACCORDING TO AETIOLOGY •Primary:idiopathic but usually immune mediated •Secondary: there is a known cause
  • 17.
    CLASSIFICATION ACCORDING TO CELLULARRESPONSE/APPEARANCE OF THE GLOMERULAR TUFT •Non-proliferative •Proliferative
  • 18.
    CLASSIFICATION ACCORDING TO HISTOLOGIC PATTERN •Focalsegmental •Diffuse •MCD •Membranous •Menbranousproliferative
  • 19.
    CLASSIFICATION OF ACCORDING TODURATION OF DISEASE •Acute GN refers to glomerular injury occurring over days to weeks. •Sub-acute or rapidly progressive GN refers to glomerular injury occurring over weeks or a few months. •Chronic GN refers to glomerular injury occurring over months or years.
  • 20.
  • 21.
    GN….BASIC DIVISION •Non- Proliferative •Minimalchange •Membranous •FSGS •Diabetes •Amyloidosis •Proliferative •Diffuse proliferative •(crescents) •Mesangiocapillary •Focal and segmental proliferative. All these are Histological patterns and NOT a diagnosis
  • 22.
    PATHOGENESIS OF GLOMERULAR INJURY •Pathogenesisof glomerular injury involves a complex interplay between •Genetic factors eg congenital Nephrotic syndrome •Acquired: Immune and Non—immune Factors Immune Mechanisms –Cellular immunity –Humoral immunity –Complement system/cascade –Coagulation cascade –Soluble factors
  • 23.
    Mechanisms of Glomerulonephritis Cell-mediatedimmune mechanismsAntibody deposits Compliment activation Influx of circulating leucocytes and cytokine and growth factor synthesis Glomerulonephritis Activation of resident cells Change in matrix On-off switch Scarring Resolution Persistant inflamation Exit of inflammatory molecules and leukocytes Genetic factors Hemodynamic factors PATHOPHYSIOLOGY.
  • 24.
  • 25.
    Genetic Factors • CongenitalNephrotic Syndrome - Mutations in nephrin - Mutation in podocin - Mutation in alpha Actinin 4 • Alport Syndrome • Thin basement membrane Disease
  • 26.
    Immune Factors •Central tothe pathogenesis GN is inflammation which is often immune mediated. •Glomeruli have three properties that make them vulnerable to immunological attack: –they “filter” and trap immune complexes –they contain immunologically competent cells capable of processing antigen –they have structures like the GBM and mesangial cells which can act as “targets” for antibodies
  • 27.
    Circulating Immune Complex •In conditions such as - SLE - HBV Infection - Malaria P. Falciparum and Malariae - Syphillis - Strptococcal infection • Deposition of immune complexes in the glomerulus which leads to complement activation, leucocytes recruitment, coagulation cascade activation and inflammation ensues
  • 28.
    In-Situ Immune Complexes •Seen in Anti-GBM Ab GN • Ab directed to fixed antigens on the GBM • Ab may also react in situ with previously planted non- glomerular antigens such as DNA, IgG, bacterial products • Ab deposition shows a linear pattern while planted antigens induce a granular pattern of immunoglobulin deposition on immunoflorescence • Ant-GBM can also cross react with alveolar basement membrane leading to simultaneous kidney/lung lesions as obtained in GoodPasture Syndrome. • Α3 chain of type IV collagen is the target antigen in anti- GBM disease (Goodpasture’s syndrome
  • 29.
    Cell mediated ImmuneGN •Cell-mediated immune mechanisms •A direct role of T cells in mediating proteinuria and crescent formation been suggested •T cells sensitized to endogenous or exogenous antigen present in the glomeruli recruit macrophages, resulting in a local delayed type hypersensitivity reaction. •There maybe no ab or immune complex deposition and and when present may not correlate with disease severity.
  • 30.
    Mediators Of ImmuneInjury •Main pathway of Ab-mediated injury is complement- leucocyte mediated •Acute injury: Predominant infiltrating cells are neutrophils and monocytes •Chronic injury:Predominant cells are monocytes/macrophages and T cells. •The primary mechanism for attracting these cells is the secretion of chemokines and the expression of leucocyte adhesion molecules by local endothelial and resident cells; •Local release of complement activation fragments (C5a) is very crucial(Chemotactic agent)
  • 31.
    Soluble Factors •Soluble factorsplay a role in the pathogenesis of glomerular disease. •Examples of soluble factors are; cytokines, chemokines, growth factors vasoactive mediators, reactive oxygen species, proteases, proteins in the coagulation cascade •These factors –promote recruitment and activation of inflammatory cells, –activate resident glomerular cells, –directly cause tissue injury, –stimulate production of matrix proteins (which forms the basis of scarring).
  • 32.
    Non-immune Factors • PodocyteInjury • Nephron Loss - Any renal condition causing significant nephron destruction and reduced GFR - Adaptive changes in the kidney such as hypertrophy to remain renal fxn occurs - Associated maladaptive haemodynamic changes utimately perpertutes renal damage and a vicious cycle ensues
  • 33.
  • 36.
  • 37.
  • 38.
  • 39.
  • 40.
    LIGHT MICROGRAPH OFA NORMAL GLOMERULUS. There are only 1 or 2 cells per capillary tuft, the capillary lumens are open, the thickness of the glomerular capillary wall (long arrow) is similar to that of the tubular basement membranes (short arrow), and the mesangial cells and mesangial matrix are located in the central or stalk regions of the tuft (arrows).
  • 41.
  • 42.
    HISTOLOGY ....MESANGIAL PROLIFERATIVE •Normal •Mesangialproliferative Light micrograph in membranoproliferative glomerulonephritis showing a lobular appearance of the glomerular tuft with focal areas of increased glomerular cellularity (large arrows), mesangial expansion (*), narrowing of the capillary lumens, and diffuse thickening of the glomerular capillary walls (small arrows).
  • 43.
    HISTOLOGY .... DIFFUSE •Normalglomerulus Diffuse endocapillary hypercellularity: post-streptococcal GN
  • 44.
  • 45.
    HISTOLOGY ..... FOCALSEGMENTAL GLOMERULOSCLEROSIS
  • 46.
  • 47.
  • 48.
    PATHOGENESIS – CHRONIC PROGRESSIVEPHASE •Renal damage in the chronic-progressive phase of GN is mediated by non-immune mechanisms that develop as a result of loss of filtering-surface with accompanying increases in glomerular pressures in remaining nephrons. •These features lead to glomerular sclerosis as well as to chronic interstitial fibrosis, which is a consequence of multiple injurious events including ischaemia, glomerular cytokine release, and toxic effects of increased protein filtration on tubules
  • 49.
    MGT:HISTORY •Family history ofkidney disease and hearing difficulties (Alport syndrome) •Medication e.g NSAID’s ACEI, penicillamine, gold, mercury in some skin lightening creams. •Recent throat infection PSGN or Viral Wegener’s granulomatosis, IgA. •Cancer - Solid tumors, Hodgkin’s (minimal change) or non Hodgkin’s (MPGN)
  • 50.
    PHYSICAL EXAMINATION •Inspection –appearance, colour, pitting oedema, xanthelasma, alopecia, facial rash, purpura, clubbing, livedo reticularis •Palpation – pulse, hepatomegaly, palpable kidneys, splenomegaly, palapable bladder •Percussion – hepatomegaly, splenomegaly •Auscultation – renal artery bruits, other bruits, cardiac lesions, hypertension,
  • 51.
  • 52.
  • 53.
  • 54.
    Useful Blood Testsin Investigations of Glomerular Disease •FBC – High white cell count in vasculitis, infections. •E &U,Cr – assesses severity of renal impairment •Total serum protein, albumin – Low in those with nephrotic syndrome •Immunoglobulins – High in vasculitis, SLE •Complement •Low C3, normal C4 in MPGN (type II) and sometimes SLE. •high C3, C4 in systemic vasculitis •Antiglomerular BM antibody – Goodpasture’s disease •Anti-dsDNA antibodies – SLE •C3 nephritic factor – MPGN (type II)
  • 55.
    Investigations… •Urinalysis •Urine Microscopy forcellular elements and casts •24 hr urinary protein estimation •Creatinine clearance or estimated GFR •Renal ultrasound •HBsAg, anti-HCV, HIV •ANCA (antineutrophil cytoplasmic antibodies) •Renal Biopsy –Light microscopy –Electron microscopy –Immunofluorescence
  • 59.
    Treatment •Control of bloodpressure –ACE inhibitors ± ARBs –Other anti-hypertensives •Blood pressure goal < 125 / 75 mm Hg if proteinuria is > 1 g /day and < 130 / 80mmHg if proteinuria is < 1 g / day. •Corticosteroids –Are effective in several types of GN owing to their ability to inhibit activity of the transcription factor nuclear factor ĸB and consequently inhibit the proinflammatory effects of cytokines known to promote glomerular inflammation actively, including interleukin 1β and tumour necrosis factor α. –Are useful in several types of GN •Lipid lowering agents e.g. statins
  • 60.
    TREATMENT •Corticosteroids •Inhibits activity ofthe transcription nuclear factors kB and consequently inhibit the pro-inflammatory effects of cytokines, known to promote glomerular inflammatory actively, including IL-Iβ and TNFα •Immunosuppressive therapies – crescentic GN, proliferative GN, FSGS, MCD, MN, IgAN with deteriorating renal function and proteinuria. •Plasmapheresis – removal of preformed antibodies from the circulation – Goodpasture’s disease
  • 61.
    TREATMENT •Immunosuppressives e.g. cyclophosphamide, azathioprine,chlorambucil, mycophenolate mofetil, sirolimus –Are of proven benefit in crescentic GN, proliferative lupus nephritis, focal and segmental glomerulosclerosis, minimal change disease, membranous nephropathy, and in cases of IgA nephropathy with deteriorating renal function and proteinuria.
  • 66.
    Conclusion • Glomerulonephritis refersto a spectrum of aetiopathogenesis and varied clinical presentations following glomerular damage • Results from complex interplay of genetic, immunologic and environmental factors • Histologic difference abound depending mostly on aetiology • May result in Acute or Chronic kidney disease • Leading cause of CKD worldwide, commonest Cause in Nigeria and Sub-Sahara Africa • Management requires early recognition by meticulous hx taking, examination and appropriate investigation • Some would require Steroid +/- Immunosuppressants
  • 67.
    References • Basic PathologyBy Robins, 8th ed • Harrison’s Principles of Internal Medicine By Longo et al, 18th ed • WACP Revision Course, 2011 • www.pubmed.gov
  • 68.

Editor's Notes

  • #45 Showing diffuse thickening